Comments on: BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE

Comments on: BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE https://medcitynews.com/2025/10/biocryst-astria-acquisition-hereditary-angioedema-rare-disease-hae-navenibart-bcrx-atxs/ Healthcare technology news, life science current events Mon, 20 Oct 2025 04:22:51 +0000 hourly 1 https://wordpress.org/?v=6.8.5